Subscribe
Call Us: 02380 97 07 33

Posts Tagged MHRA

Drug Safety Update – Atypical femoral fractures with Bisphosphonates

Drug Safety Update – Atypical femoral fractures with Bisphosphonates

Atypical femoral fractures have been reported rarely with bisphosphonate therapy, mainly in patients receiving long-term treatment for osteoporosis. Discontinuation of bisphosphonate therapy in patients suspected to have an atypical femur fracture should be considered while they are evaluated, and should be based on an assessment of the […]

Read more

Drug Safety Alert – Dronedarone

Drug Safety Alert – Dronedarone

Dronedarone (Multaq▼) is an antiarrhythmic agent indicated in adult, clinically stable patients with history of, or current, non-permanent atrial fibrillation (AF) to prevent recurrence of AF or to lower ventricular rate. Dronedarone is available as a 400 mg film-coated tablet and the recommended dose is 400 mg […]

Read more

Class 3 Drug Alert: Novgos 3.6 mg Implant

Class 3 Drug Alert: Novgos 3.6 mg Implant

Action within 5 days Genus Pharmaceuticals Ltd is temporarily ceasing manufacture of the above product and recalling all remaining stock from pharmacy and wholesaler level. This is due to a small number of problems during implantation and the product is being withdrawn until the implantation system can […]

Read more

Class 2: Drug Alert – Gaviscon Advance

Class 2: Drug Alert – Gaviscon Advance

Gaviscon Advance Peppermint Flavour Oral suspension containing sodium alginate 500mg and potassium bicarbonate 100mg in 5ml PL 0063/0103 Batch Number Expiry Date Pack Size First Distributed 924471 1/08/2011 500 ml bottle 19/09/2009 925071 1/09/2011 500 ml bottle 19/09/2009 Reckitt Benckiser Healthcare (UK) Ltd are recalling the above […]

Read more

Drug Safety Information – Phenergan Elixir

Drug Safety Information – Phenergan Elixir

MHRA has just posted this Drug Safety Information with respect to Phenergan Elixir PL 04425/0630, 100ml packs. The labelling may “cause confusion to diabetic patients”. This relates to the technical distinction between hydrogenated glucose (which is not considered as sugar and therefore does not carry the risks […]

Read more

Update 04 – 10/03/09

Click here to view update

Read more

Another Class 4 Alert

Another Class 4 Alert

The MHRA has just posted another Class 4 Alert relating to the patient information leaflet (PIL) of Timoptol-LA 0.25% w/v & 0.5% w/v Gel-Forming Eye Drops Solutions. The dose printed on the PIL is wrong. It states a dose of twice a day instead of the correct […]

Read more

Children’s OTC New Advice – bookapharmacist response

Children’s OTC New Advice – bookapharmacist response

MHRA, the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe recently issued a new advice for children’s over the counter cough and cold medicine ( link ). The landmark finding is that these over the counter cough and […]

Read more

Important – Class 4 Alert

Important – Class 4 Alert

We have just been alerted to this packaging issue with Priadel 400mg Prolonged Release. The labelling on the rear panel of the cartons are wrong. On the side of the box where you place the dispensing label, you have Lithium Carbonate 200mg incorrectly printed on it. Please […]

Read more
Page 2 of 212

Disclaimer

The information on this site is provided 'as is' Whilst we stake our reputation on producing the most accurate information (and employ reasonable care and skill in providing this site's content), we cannot warrant that the information is accurate, complete and up to date. Neither can we guarantee uninterrupted performance and durability.
Click here to read our complete terms and conditions.